6 August, 2025

A Strategic Pharmacovigilance Checklist for Biosimilar Safety in 2025

Insights Hub

At PrimeVigilance, biosimilar safety isn’t just part of our service offering—it’s a core area of expertise shaped by decades of hands-on experience across global markets.

With regulatory requirements evolving and healthcare systems under pressure to embrace cost-effective alternatives, biosimilars demand a tailored, forward-thinking pharmacovigilance strategy. From risk management planning to real-time signal detection, ensuring patient safety across the biosimilar lifecycle requires more than just compliance—it calls for operational precision, proactive oversight, and deep regulatory insight.

In this free resource, we share a strategic 10-point checklist designed to help PV teams stay ahead of 2025 regulatory expectations. You’ll discover how PrimeVigilance supports clients in navigating interchangeability, aligning global labeling, leveraging AI-based detection systems, and ensuring seamless launch readiness across complex product portfolios.

Please submit form to access content.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Job Title

Industry*

Company*

Business Email*

Phone

Country*

State*

By submitting this form, you consent to your personal data being processed in alignment with our privacy policy. Your personal data will be processed for purpose of facilitating your request and may be used for sending you additional marketing and business development-related information about PrimeVigilance, its affiliates and our services. You can withdraw your consent at any time at marketing@ergomedgroup.com, and your personal data will be erased. For more information about our privacy policy and your privacy rights, please visit our website’s data policy section.